blog

Clinical Review Favors Targeted Testing for Bloating

A clinical commentary revisits when bloating calls for testing and how constipation patterns, alarm features and clinical context guide evaluation.

Clinical Review Favors Targeted Testing for Bloating
Share
PinterestFacebookLinkedInWhite Reddit alien mascot face icon on transparent background.White paper airplane icon on transparent background.White stylized X logo on black background, representing the brand X/Twitter.
Nov 2, 2026
Bloating & Regularity

On October 30, 2026, Medscape published Alicia H. Muratore’s clinical commentary arguing for symptom-matched testing rather than automatic scopes or scans for bloating. It emphasizes existing guidance that separates uncomplicated symptoms from patterns suggesting a need for further evaluation.

Selective testing was already part of gastroenterology guidance

The October commentary revisits an existing position rather than reversing one. As Medscape explains, the American Gastroenterological Association’s 2023 Clinical Practice Update already supported selective evaluation for bloating and abdominal distension. The commentary also draws on the American College of Gastroenterology’s guidance on irritable bowel syndrome and small-intestinal bacterial overgrowth.

The underlying distinction is between symptoms that call for a focused clinical assessment and findings that justify additional investigation. In Medscape’s account of the AGA guidance, routine laboratory tests, imaging and endoscopy are generally unnecessary when symptoms are stable without alarm features and the physical examination is normal.

That is not an argument for ignoring discomfort. It is a framework for choosing an investigation because it answers a clinical question rather than treating every report of bloating as a reason for the same workup. The recommendation depends on clinical assessment, not on a reader deciding that a symptom is harmless.

A 2026 article in Digestive Diseases and Sciences describes a similar starting point for constipation. It says evaluation typically begins with a medical history and physical examination, including a digital rectal examination. This places the conversation and examination before decisions about specialized testing.

The review puts the reason for each test first

The practical value of the October review is how it organizes existing recommendations around accompanying symptoms. Instead of treating bloating as a single testing category, it asks what else is happening and which question an investigation might answer.

This moves the discussion beyond whether bloating is severe enough to deserve attention. Someone can need a thoughtful care plan without needing a scope. Another symptom pattern may give a clinician a specific reason to investigate further.

Constipation can point to different testing questions

Medscape describes a colonic transit study as a possible evaluation when constipation suggests slow transit. When pelvic-floor dysfunction is suspected, it describes anorectal manometry and a balloon-expulsion test.

Slow transit concerns movement through the colon. An evacuation problem concerns passing stool. These are different clinical questions even when both arise during a conversation about constipation and bloating.

Supporting context comes from the 2026 Digestive Diseases and Sciences article. It describes specialized anorectal and transit testing as selective options for constipation that is refractory or has features suggesting a defecation disorder or slow transit. Here, refractory means symptoms that have not responded to management.

The distinction matters because a constipation test is not one investigation with one purpose. The suspected problem helps determine which test might be useful. The review’s examples do not mean that bloating with constipation automatically leads to either testing pathway.

A useful question for a care visit is whether the pattern suggests slow transit or difficulty with evacuation, and whether testing would help clarify that distinction. This invites an explanation of the proposed investigation without assuming that a particular test is necessary.

Alarm features change the evaluation

Muratore lists findings that may prompt a more structured evaluation. The review includes:

  • Gastrointestinal bleeding or vomiting.
  • Substantial unintentional weight loss.
  • New or substantially changed bowel habits.
  • A family history of gastrointestinal cancer.
  • Rapidly progressive abdominal pain or dyspepsia, meaning indigestion.

The review also highlights new-onset bloating in women over 50 as a reason to consider evaluation for ovarian disease. Iron-deficiency anemia without a clear source is another finding it identifies.

These are reasons for clinician-led assessment rather than a way to diagnose the cause of bloating at home. They also explain why the recommendation against routine testing should not be separated from its clinical conditions. Related reading on distinguishing everyday discomfort from reasons to seek care can help frame that conversation.

The practical distinction is between ordering tests automatically and investigating a specific concern. Selective testing does not mean withholding an appropriate evaluation when the symptom pattern or examination raises a different question.

Accompanying symptoms guide other testing options

Other examples in the Medscape commentary connect test choices to symptoms beyond constipation. For bloating with diarrhea, it describes celiac serology and fecal calprotectin testing. For bloating with dyspepsia, it discusses upper endoscopy with Helicobacter pylori testing, particularly in patients over 40.

The review also describes fecal elastase testing for steatorrhea, meaning fatty stools, or unexplained weight loss. These are clinician-directed examples matched to particular presentations rather than a package of tests for everyone with digestive discomfort.

The useful point for readers is not to memorize the test names. It is to understand why the accompanying symptom changes the clinical question. Asking what a proposed test is intended to investigate keeps the discussion focused on its purpose rather than the number of investigations ordered.

SIBO testing is not the default response

The review also questions the routine use of breath testing for small-intestinal bacterial overgrowth, or SIBO. Medscape describes testing as an option for people with specific risk factors or severe symptoms that remain refractory. It does not present breath testing as the first step for uncomplicated bloating.

The commentary emphasizes pretest probability, meaning how likely the condition seems before a test is performed. According to Medscape, testing people with a low likelihood of SIBO risks misinterpreting a positive result.

In this framework, a positive result needs clinical context rather than being treated as an explanation on its own. The decision begins with whether there is a sound reason to suspect the condition. That is a different approach from choosing a test simply because bloating appears among the symptoms associated with it.

The commentary does not establish a new testing standard

The central limitation is the kind of publication involved. Muratore’s article is clinical commentary, not a newly released clinical trial or an updated society guideline. It interprets existing guidance rather than providing new patient-level evidence comparing testing strategies.

The accessible text also does not supply full citations for each recommendation adapted from gastroenterology guidance. Its claims about low diagnostic yield and procedural risks from overtesting are not accompanied by quantified outcomes or a specific cited study. The article therefore does not establish how much benefit a particular reader would gain from avoiding or undergoing a test.

The 2026 Digestive Diseases and Sciences article supplies adjacent support for selective constipation testing. It does not independently verify every recommendation in the Medscape commentary. Its role here is to provide related context for how specialized testing fits into constipation assessment.

Food advice deserves the same evidence check. The commentary discusses a targeted dietary elimination trial but provides no trial data showing how accurately that approach identifies a food trigger. That discussion does not establish a validated dietary diagnostic method.

Food decisions should complement clinical evaluation

For daily food choices, the realistic implication is to keep evaluation and dietary experimentation in their proper roles. The review’s main contribution is a way to think about testing, not a new menu or a universal treatment plan. Decisions about recurring symptoms and investigations belong in a conversation with a qualified clinician.

A decision against routine scopes does not automatically point toward an elimination diet. Likewise, changing foods should not become a substitute for discussing a new or concerning symptom pattern. Readers weighing restriction may find considering symptom patterns before removing foods a more useful starting point than assuming one ingredient explains everything.

The next care conversation can focus on the reason for the plan: which features informed the assessment and what any proposed test is expected to clarify. If testing is not recommended, asking about the management plan keeps the discussion moving beyond the absence of a procedure.

The takeaway is modest but useful. Better-targeted evaluation is the goal, while more testing and more food restriction are not goals in themselves. This commentary supports a more focused conversation about bloating rather than a new set of dietary rules.

How DigestGenius helps

Once the testing question is settled, interpreting recurring bloating and bowel patterns becomes the next task, supported by DigestGenius’s nutrition and digestive-health education. Its free learning platform helps adults put confusing digestive experiences into research context, with plain-language coverage of everyday gut function that distinguishes established evidence from emerging findings.

Explore the Blog

Sources

  1. Overlooked and Undertreated: National Shortfalls in Anorectal ...
  2. Bloating: When to Scope, When to Not

DigestGenius publishes research-led guidance on digestion, the gut microbiome, fiber, probiotics, gut-brain signaling, inflammation and everyday digestive wellbeing.

FacebookInstagramYouTubeXPinterest

Continue reading

New IBS Fiber Guide Puts Serving Sizes in Context
November 22, 2026
Food, Fiber & Nutrition

New IBS Fiber Guide Puts Serving Sizes in Context

read article
Why do bloating and constipation often happen together?
November 22, 2026
Bloating & Regularity

Why do bloating and constipation often happen together?

read article
How 24-Hour Body Clocks and Stress Patterns Drive Changes in Colon Activity and Microbes
November 21, 2026
Gut-Brain & Lifestyle

How 24-Hour Body Clocks and Stress Patterns Drive Changes in Colon Activity and Microbes

read article
understand your gut

Keep learning what supports a healthier gut

Explore clear, research-led guidance on digestion, the microbiome, food, fiber, probiotics and the gut-brain connection.

read the blog
Woman holding a colorful plant-rich bowl in a bright kitchen